BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33284091)

  • 1. Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice.
    Kobayashi M; Kasamatsu S; Shinozaki S; Yasuhara S; Kaneki M
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E150-E159. PubMed ID: 33284091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.
    Smith IJ; Aversa Z; Alamdari N; Petkova V; Hasselgren PO
    J Cell Biochem; 2010 Nov; 111(4):1059-73. PubMed ID: 20677217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    Castillero E; Nieto-Bona MP; Fernández-Galaz C; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E790-9. PubMed ID: 21304067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
    Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis.
    Lee SJ; Gharbi A; Shin JE; Jung ID; Park YM
    Biochem Biophys Res Commun; 2021 Mar; 543():1-7. PubMed ID: 33588136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
    Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
    Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
    Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
    Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
    Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
    Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.
    Heineke J; Auger-Messier M; Xu J; Sargent M; York A; Welle S; Molkentin JD
    Circulation; 2010 Jan; 121(3):419-25. PubMed ID: 20065166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of activins promotes muscle wasting and cachexia.
    Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
    FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive Effects of Schisandrin A, A Bioactive Component of
    Yeon M; Choi H; Jun HS
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32354126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle.
    D'Orlando C; Marzetti E; François S; Lorenzi M; Conti V; di Stasio E; Rosa F; Brunelli S; Doglietto GB; Pacelli F; Bossola M
    Muscle Nerve; 2014 Apr; 49(4):528-33. PubMed ID: 23835743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
    Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway.
    Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.